Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Naomi Shimada"'
Autor:
Naomi Shimada, Tomohiro Nakayama, Hiroshi Umemura, Kei Kawana, Tatsuo Yamamoto, Seisaku Uchigasaki
Publikováno v:
Medicina, Vol 58, Iss 5, p 591 (2022)
Hypertensive disorders of pregnancy (HDPs) are believed to comprise a group of multifactorial genetic diseases. Recently, it was reported that APELA-knockout mice exhibited HDP-like symptoms, including proteinuria and elevated blood pressure due to d
Externí odkaz:
https://doaj.org/article/3e328618617049848616ab3204ebb1be
Autor:
Hitoshi Uchiyama, Masayuki Tsujimoto, Naomi Shimada, Koji Tsutsui, Ayaka Nitta, Takuya Yoshida, Taku Furukubo, Satoshi Izumi, Tomoyuki Yamakawa, Hidehisa Tachiki, Tetsuya Minegaki, Kohshi Nishiguchi
Publikováno v:
Toxins, Vol 10, Iss 2, p 53 (2018)
Patients with end-stage kidney disease (ESKD) are at higher risk for rhabdomyolysis induced by statin than patients with normal kidney function. Previously, we showed that this increase in the severity of statin-induced rhabdomyolysis was partly due
Externí odkaz:
https://doaj.org/article/05f46d0ead054cedabfaf0ff7c448144
Publikováno v:
Molecular Biology Reports. 45:925-929
Analysis of DNA polymorphisms are the primary technique used for personal identification in forensic cases. However, DNA samples collected as evidence from crime scenes are usually degraded by environmental, physical, and chemical factors, which may
Autor:
Naomi Shimada
Social media has changed our aspirations and the way we see ourselves. It has created a new layer of perfectionist pressure in every aspect of our lives, but equally enabled us to share resources, opinions, help and information more quickly than ever
Autor:
Hajime Suzuki, Mitsuyoshi Nakamura, Junichiro Sawa, Ayaka Sano, Takanori Tsuda, Ryuichi Ebisawa, Jotaro Shinagawa, Xinbin Qiu, Yayoi Kondo, Nobuyuki Shiga, Koji Ando, Akihiro Maruhashi, Naomi Shimada, Hiromi Sasamoto
Publikováno v:
Annals of Oncology. 30:vi94-vi95
Background Clinical Research Organizations (CROs) have been required to ensure delivery of expertise and high-quality services and promptly conduct a clinical trial. Shortening the duration of a clinical trial is considered to have a great impact on
Autor:
Asuka Yamamoto, Taro Amagasaki, Kazuto Natsume, Margaret M. Woo, Yoichiro Ogama, Tomoko Mineyama, Naomi Shimada
Publikováno v:
International Journal of Hematology. 97:351-359
Ruxolitinib (INC424), a potent and selective oral Janus kinase 1 and 2 inhibitor, was recently approved by the US food and drug administration for the treatment of intermediate or high-risk myelofibrosis. The safety, tolerability, and pharmacokinetic
Autor:
Hitomi Ohya, Chieko Mitsui, Mitsuhiro Kameyama, Ryuji Kawahara, Manabu Ato, Hisako Nihonmatsu, Mari Sasaki, Naomi Shimada, Takayuki Matsumura, Tadayoshi Ikebe, Makoto Ohnishi, Rumi Okuno
Publikováno v:
Scientific Reports
Streptococcus pyogenes (group A Streptococcus; GAS) is a widespread human pathogen and causes streptococcal toxic shock syndrome (STSS). STSS isolates have been previously shown to have high frequency mutations in the csrS/csrR (covS/covR) and/or rgg
Autor:
Xinbin Qiu, Akihiro Maruhashi, Jotaro Shinagawa, Naomi Shimada, Hiromi Sasamoto, Takanori Tsuda, Nobuyuki Shiga, Yotaro Izumi, Koji Ando, Mari Omae, Hajime Suzuki, Ayaka Sano
Publikováno v:
Annals of Oncology. 29:vii70
Autor:
Ken Kobayashi, Michinori Ogura, Toshiki Uchida, Masafumi Taniwaki, Dai Maruyama, Kenichi Ishizawa, Ilseung Choi, Kensei Tobinai, Kuniaki Itoh, Kiyoshi Ando, Naomi Shimada, Naokuni Uike
Publikováno v:
International Journal of Hematology. 92:563-570
Phase I study was conducted to evaluate the safety, pharmacokinetics (PK) and efficacy of the oral mammalian target of rapamycin inhibitor, everolimus (RAD001), in patients with relapsed or refractory non-Hodgkin lymphoma (NHL). Patients received eve
Autor:
Taku Furukubo, Kohshi Nishiguchi, Hidehisa Tachiki, Koji Tsutsui, Tomoyuki Yamakawa, Naomi Shimada, Takuya Yoshida, Ayaka Nitta, Masayuki Tsujimoto, Satoshi Izumi, Hitoshi Uchiyama, Tetsuya Minegaki
Publikováno v:
Toxins; Volume 10; Issue 2; Pages: 53
Toxins
Toxins, Vol 10, Iss 2, p 53 (2018)
Toxins
Toxins, Vol 10, Iss 2, p 53 (2018)
Patients with end-stage kidney disease (ESKD) are at higher risk for rhabdomyolysis induced by statin than patients with normal kidney function. Previously, we showed that this increase in the severity of statin-induced rhabdomyolysis was partly due